FAKTOR-OPTIONSSCHEIN - YPSOMED N Share Price

Certificat

DE000MA12QR5

Delayed Börse Stuttgart 08:54:19 03/06/2024 BST
58.04 EUR +3.57% Intraday chart for FAKTOR-OPTIONSSCHEIN - YPSOMED N
1 month+34.32%
3 months+2.81%
Date Price Change
03/06/24 58.04 +3.57%
31/05/24 56.04 -3.41%
30/05/24 58.02 +1.19%
29/05/24 57.34 -5.05%
28/05/24 60.39 +3.71%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 08:54 am

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying YPSOMED HOLDING AG
Issuer Morgan Stanley
WKN MA12QR
ISINDE000MA12QR5
Date issued 21/08/2020
Strike 191.1 CHF
Maturity Unlimited
Parity 3.48 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 61.03
Lowest since issue 6.94
Spread 0.64
Spread %1.07%

Company Profile

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Sector
-
More about the company

Ratings for Ypsomed Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Ypsomed Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
382 CHF
Average target price
362 CHF
Spread / Average Target
-5.24%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW